Opendata, web and dolomites
H2020 projects about "metastatic"
The page lists 138 projects related to the topic "metastatic".
| # | |||
|---|---|---|---|
| 1 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 2 | INTRAHETEROSEQ | Molecular characterization of the role of intra-tumor heterogeneity in cancer progression and metastasis | 2015 |
| 3 | EPICUP | Development of a ncRNA DNA Methylation Kit for the Diagnosis of Cancer of Unknown Primary | 2015 |
| 4 | A CACTUS | Antibody-free method for Counting All Circulating TUmour cellS while maintaining them alive and intact | 2015 |
| 5 | Cancer-Targeted PolyIC | Treatment of EGFR over-expressing cancers by targeted non-viral delivery of PolyIC | 2015 |
| 6 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 7 | BioGuidePCa | Biomarker Guided Prostate Cancer Management | 2014 |
| 8 | Brain Metastases | The Role of Circulating Monocytes in the Development of Brain Metastases | 2015 |
| 9 | Cdc42Adhere | Role of Cdc42 in cancer cell adhesion to endothelial cells and platelets | 2015 |
| 10 | GENMETASTEM | GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS | 2016 |
| 11 | MACROIMAGING | Specific Fluorogenic Peptides for Imaging Metastasis-associated Macrophages | 2015 |
| 12 | MatrixMacrophages | Matrix degrading macrophages in cancer growth and invasion | 2015 |
| 13 | BRIDGES | Bioinformatic approaches to identify and detect both disease- and drug-related genomic alterations in breast cancer patients | 2015 |
| 14 | S-OS | Exosomes as microenvironmental cue for engaging mesenchymal stem cells in osteosarcoma progression | 2016 |
| 15 | CELLETEST | Liquid Biopsy blood test in lung cancer diagnosis and monitoring: a next generation noninvasive tumor tracker device | 2015 |
| 16 | MyNano | Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients | 2015 |
| 17 | ER_disease | Defining hormonal cross-talk and the role of mutations in estrogen receptor positive breast cancer | 2015 |
| 18 | ZF-MEL-CHEMBIO | Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma | 2015 |
| 19 | PROTEOMICAN | Discovery of breast cancer aggressiveness markers using topo-proteomics mapping | 2015 |
| 20 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
| 21 | ISPIC | Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome | 2016 |
| 22 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 23 | uPET | Molecular imaging and targeted therapy of the aggressive phenotype: development of uPAR theranostics for cancer patients | 2015 |
| 24 | AVATAR | Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment | 2015 |
| 25 | CYTOPRO | Profiling of tumour cells in blood for personalized treatment of metastatic cancer | 2015 |
| 26 | RCC-TEST | A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test | 2016 |
| 27 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 28 | HERCULES | Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | 2016 |
| 29 | UM Cure 2020 | New therapies for uveal melanoma | 2016 |
| 30 | FORCE | Imaging the Force of Cancer | 2016 |
| 31 | Bcl-Inhib | Discovery of Bcl-3 inhibitors as Potential Chemopreventive Agent for skin cancer | 2015 |
| 32 | PrECISE | PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION | 2016 |
| 33 | HOLDING-HANDS | Holding hands: cell-cell junctions in breast cancer metastasis and resistance to therapy | 2016 |
| 34 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 35 | PDA_TGFb | TGF-beta mediated crosstalk between cancer (stem) cells and tumor microenvironment in pancreatic cancer metastasis | 2017 |
| 36 | RAC | Defining the Role of Antioxidants on Cancer progression and metastasis | 2016 |
| 37 | MRCKa in cancer | Targeting Cancer Cell Invasion and Metastasis by Inhibition of the Serine Kinase MRCKa | 2016 |
| 38 | DLL4-LVN | Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma | 2017 |
| 39 | 2MoveMate4Melanoma | A treatment for BRAF inhibitor resistant melanoma | 2016 |
| 40 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 41 | FIBROCAN | Defining the immunological interplay between fibroblastic reticular cells and anti-tumour T cells | 2016 |
| 42 | STEM-BCPC | Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer | 2016 |
| 43 | Project ACT | Automated autologous cell therapy system | 2016 |
| 44 | NO-META | Feasibility study of a NOvel METAbolic liquid biopsy for cancer therapy monitoring | 2016 |
| 45 | tagMDR | Identification of Multidrug Resistance for Chemotherapy Guidance in Cancer Using a Lab-on-a-chip Platform | 2016 |
| 46 | MATRICAN | Matrix during cancer progression | 2016 |
| 47 | EPIPHARM | Development of a ncRNA DNA Methylation Kit for Treatment Guidance in Cancer of Unknown Primary | 2017 |
| 48 | HypoSens | Nano-confined photonic system for detection of breast cancer spread to the lymph nodes | 2016 |
| 49 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
| 50 | GlycoImaging | Imaging and detection of tumor-associated glycan structures on tumor cells | 2017 |
| 51 | IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer | 2017 |
| 52 | SUPRACELL_COMMUN_CCT | Supracellular contractility dynamics and cell communication during collective chemotaxis. | 2016 |
| 53 | MetResistance | The role of tumour microenvironment in metastatic hormone-refractory prostate cancer | 2017 |
| 54 | SpheroPredict | A 3D advanced test for prediction of drug response in secondary liver cancer | 2017 |
| 55 | Monomark | A comparative clinical study of a stool-based versus a blood-based screening test for earlydetection of CRC | 2017 |
| 56 | TRIBBLES | Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma | 2018 |
| 57 | METMEL | Long range-acting drivers of premetastatic niches in melanoma | 2017 |
| 58 | CINK | Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 |
| 59 | WHOLENICHE | Hold it or let it go: a niche decision on cancer growth | 2017 |
| 60 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 61 | CTCapture_2.0 | Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patients | 2017 |
| 62 | META-DORM | Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions | 2018 |
| 63 | HoldCancerBack | What Holds Cancer Cells Back? | 2017 |
| 64 | STOPCa | The cryptic path of tumor-microenvironment interactions in prostate cancer | 2017 |
| 65 | COLOSSUS | Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions | 2018 |
| 66 | MTrix | Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine | 2017 |
| 67 | CombaTCancer | Rational combination therapies for metastatic cancer | 2018 |
| 68 | CANCER | Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | 2018 |
| 69 | MATADOR | MAmmary chemoresistant Tumor deAth by Directed cell ORientation | 2018 |
| 70 | OMVCRC | Engineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapy | 2018 |
| 71 | MicroCaT | Micro-tumor Guided Cancer Therapy Selection MicroCaT | 2018 |
| 72 | MetaRegulation | Metabolic regulation of metastatic growth | 2018 |
| 73 | iaFRET | An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinicalefficiency of personalised cancer treatments to an unprecedented level. | 2018 |
| 74 | IMMUNOMARK | Omics integration for precision cancer immunotherapy | 2018 |
| 75 | PhenoSwitch | Phenotype switching: plasticity and/or differentiation of stromal cells and their progenitors within the tumour microenvironment regulate tumour fate. | 2018 |
| 76 | ONCOTHERANOSTICS | Advanced Theranostic Nanomedicines for Oncology. Development of new combinatorial therapies for primary and metastatic Breast Cancer. | 2019 |
| 77 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
| 78 | COLOVOC | Reliable and specific urinary biomarkers for colorectal cancer | 2019 |
| 79 | VulneraBAP1 | Mechanism and vulnerability of BAP1 loss in tumor metastasis | 2018 |
| 80 | NANOBOTS | Tumor-Targeting Nanoengineered Bioorthogonal Technologies to Fight Metastatic Cancers | 2018 |
| 81 | PCaProTreat | Multi-omics molecular treatment targets for Prostate Cancer | 2018 |
| 82 | GDCOLCA | Understanding gamma delta T cells in colon cancer metastasis | 2018 |
| 83 | QuanTII | Quantitative T cell Immunology and Immunotherapy | 2018 |
| 84 | B2B | Modeling spontaneous Breast cancer metastasis TO the Bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity. | 2018 |
| 85 | LIPOMET | Dietary Influences on Metastasis: How, When, and Why | 2018 |
| 86 | RV001 | RV001: An anti-metastatic cancer vaccine | 2018 |
| 87 | SMARTRIOX | Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles | 2018 |
| 88 | TETHIS-SBS-CTC | TETHIS-SBS-CTC: An innovative diagnostic testing platform to identify and characterize circulating tumour cells (CTCs) in blood samples. | 2018 |
| 89 | UNLEASHAD | Unleashing the curative potential of cancer immunotherapy | 2018 |
| 90 | CytoPro | A breakthrough cancer diagnostic instrument to save 3000 years of human lives annually and up | 2018 |
| 91 | ImmunoCode | Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy | 2018 |
| 92 | FURTHER | Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone Metastasis | 2019 |
| 93 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 94 | METANICHE | Regulation of bone metastases by age-associated angiocrine signals | 2019 |
| 95 | CANCEREVO | Deciphering and predicting the evolution of cancer cell populations | 2019 |
| 96 | FanCY | Flow and Deformation of Cancer tumours near Yielding | 2019 |
| 97 | PACA-MET | Genome-wide surveys and functional analysis of pancreatic cancer metastasis drivers | 2019 |
| 98 | PREFERABLE | Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life | 2019 |
| 99 | AURORAX | Advancing cancer detection through metabolism-based diagnostics | 2019 |
| 100 | POCON | Proof-of-Concept of a nanobody targeting Osteopontin to inhibit colorectal cancer development | 2019 |
| 101 | Cluster-Buster | Development of small molecule inhibitors of circulating tumor cell clusters | 2019 |
| 102 | CRC-MTOs | Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing | 2018 |
| 103 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 104 | INHuMAN | Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma | 2019 |
| 105 | EVOMET | The rise and fall of metastatic clones under immune attack | 2019 |
| 106 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
| 107 | EndoPos | Endosome positioning in tumour-stroma interactions | 2019 |
| 108 | AR-DDR | Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer | 2019 |
| 109 | PB_dormancy | Insertional mutagenesis to identify molecular mechanisms of breast cancer dormancy and metastasis | 2020 |
| 110 | MetaTarGet | Targeting metabolic regulation in metastasis formation | 2019 |
| 111 | IEOCCD | THE IMPACT OF THE ENVIRONMENT AND ONCOGENESIS ON CANCER CELL DIVISIONS | 2019 |
| 112 | MechTransition | Regulatory mechanisms controlling a new mechanical Epithelial to Mesenchymal Transition in zebrafish | 2020 |
| 113 | PDX-PC | Elucidation of tumour cell plasticity mechanisms associated to treatment in metastatic prostate cancer | 2019 |
| 114 | INFORM | Innovative Electrochemical Multiplex Biosensor for Detection and Quantification of Clinically Relevant Circulating miRNAs | 2020 |
| 115 | ICE-METs | Interstitium-on-a-chip to explore its role in cancer metastasis | 2019 |
| 116 | METASPINE | Comprehensive experimental and computational mechanical characterisation of metastatic vertebrae | 2019 |
| 117 | NanoProt-ID | Proteome profiling using plasmonic nanopore sensors | 2019 |
| 118 | PROTEUS | Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection | 2019 |
| 119 | CHyMERA | Monitoring cancer heterogeneity based on the dynamic assessment of the Warburg effect under metabolic perturbation | 2019 |
| 120 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 121 | MS | Unravelling the molecular and cellular mechanism of metastasis | 2020 |
| 122 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
| 123 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 124 | THERADNET | International NETwork for training and innovations in THErapeutic RADiation | 2019 |
| 125 | PAVE | A nanovaccine Approach for the treatment of Pancreatic Cancer | 2019 |
| 126 | RV001 | RV001: An anti-metastatic cancer vaccine | 2019 |
| 127 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 128 | ImOPac | GemciTest: An innovative In Vitro Diagnostic for the decision-making process of pancreatic cancer treatment | 2019 |
| 129 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
| 130 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
| 131 | ALTER-brain | Metastasis-associated altered molecular patterns in the brain | 2020 |
| 132 | BRCAstem | Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells | 2020 |
| 133 | METABONE | A new approach of metastatic bone fracture prediction using a patient-specific model including metastatic tissue, daily-life activities and local failure criteria | 2020 |
| 134 | NetriCan | Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. | 2020 |
| 135 | NANOCRISPR | NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS | 2021 |
| 136 | RabTarget4Metastasis | Targeting Rab27A with covalent inhibitors for the treatment of metastatic breast cancer | 2020 |
| 137 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |
| 138 | RCC_Evo | Modelling the Predictability and Repeatability of Tumour Evolution in Clear Cell Renal Cell Cancer | 2020 |